News Conference News AHA 2024 REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients L.A. McKeown November 22, 2024
News Conference News AHA 2024 Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression Yael L. Maxwell November 20, 2024
Presentation AHA 2024 Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations Presenter: Daniel Bensimhon November 18, 2024
News Conference News AHA 2024 Nasal Bumetanide Safe, Effective in Healthy Adults Yael L. Maxwell November 18, 2024
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Daily News Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA L.A. McKeown July 02, 2024
News Conference News ESC Heart Failure 2024 Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients Michael O'Riordan May 13, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024